05.11.2014 Views

Admission Document - BrainJuicer

Admission Document - BrainJuicer

Admission Document - BrainJuicer

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

agreement can be terminated upon six months’ notice in writing by either party and includes<br />

restrictive covenants which apply during his employment and for a period of 12 months after its<br />

termination. These covenants cover non-competition, non-solicitation and non acceptance of business<br />

from customers and non-solicitation of employees and consultants. There is also a restrictive covenant<br />

covering non interference with supplies to <strong>BrainJuicer</strong> UK which applies for six months from the<br />

termination of employment. John’s basic remuneration is £112,750 per annum. John is entitled to a<br />

bonus of up to 30 per cent. of his annual salary if <strong>BrainJuicer</strong> UK achieves gross profit margin targets<br />

and profit targets for the Group are met. The sum paid is then determined from the size of these profits<br />

and individual performance. In practice, no bonus payment was made in 2005 and 4.5 per cent. has<br />

currently been paid for 2006. He also benefits from private and health insurance (with effect from<br />

September this year) available to all employees of <strong>BrainJuicer</strong> UK. It is currently intended that life<br />

and permanent health insurance will be made available to all employees of <strong>BrainJuicer</strong> UK with effect<br />

from January next year and that he will benefit from this on the same terms as those offered to<br />

employees. John entered into a letter of appointment as an executive director of the Company on 30<br />

November 2006. John’s appointment can be terminated on six months’ notice in writing by John or<br />

the Company. John is not entitled to receive a fee over and above his remuneration pursuant to his<br />

service agreement with <strong>BrainJuicer</strong> UK.<br />

(c)<br />

(d)<br />

(e)<br />

(f)<br />

James Brodie Geddes was appointed as Director of the Company on 5 October 2006 and as a director<br />

of <strong>BrainJuicer</strong> UK on 22 January 2003. James’s current service agreement with <strong>BrainJuicer</strong> UK is<br />

dated 22 January 2003. This agreement confirms his appointment as Chief Financial Officer. The<br />

agreement can be terminated upon 12 months’ notice in writing by the Company or 6 months’ notice<br />

in writing by James and includes restrictive covenants which apply during his employment and for a<br />

period of 12 months after its termination. These covenants cover non-competition, non-solicitation<br />

and non acceptance of business from customers and non-solicitation of employees and consultants.<br />

There is also a covenant covering a non interference with supplies to <strong>BrainJuicer</strong> UK and applies for<br />

six months from termination of employment. James’ basic remuneration is £92,250 per annum. James<br />

is entitled to a bonus of up to 30 per cent. of his annual salary if <strong>BrainJuicer</strong> UK achieves gross profit<br />

margin targets and profit targets for the Group are met. The sum paid is then determined from the size<br />

of these profits and individual performance. In practice, no bonus payment was made in 2005 and 4.5<br />

per cent. has currently been paid for 2006. He also benefits from private and health insurance (with<br />

effect from September this year) available to all employees of <strong>BrainJuicer</strong> UK. It is currently intended<br />

that life and permanent health insurance will be made available to all employees <strong>BrainJuicer</strong> UK with<br />

effect from January next year and that he will benefit from this on the same terms as those offered to<br />

employees. James entered into a letter of appointment as an executive director of the Company on 30<br />

November 2006. James’ appointment can be terminated on six months’ notice in writing by James or<br />

12 months’ notice by the Company. James is not entitled to receive a fee over and above the<br />

remuneration pursuant to his service agreement with <strong>BrainJuicer</strong> UK.<br />

Mark Philip Muth was appointed as a non-executive director of the Company on 5 October 2006 and<br />

entered into a letter of appointment with the Company on 30 November 2006. Mark’s appointment<br />

can be terminated on six months’ notice in writing by Mark but the Company has undertaken not to<br />

exercise its right to terminate on six months’ notice in writing to Mark for so long as Unilever UK<br />

Holdings remains the registered holder of not less than 10 per cent. of the issued share capital of the<br />

Company. Mark will not be entitled to receive a fee in respect of the performance of his duties as a<br />

non-executive director.<br />

Simon Cedric Valentine Godfrey was appointed as a non-executive director of the Company on<br />

5October 2006 and entered into a letter of appointment with the Company on30 November2006.<br />

Simon’s appointment can be terminated on six months’ notice in writing by Simon Godfrey or the<br />

Company. Simon will be entitled to a fee of £40,000 per annum.<br />

Jonathan Perry Rimmer entered into a service agreement with <strong>BrainJuicer</strong> UK dated 12 September<br />

2006. This agreement confirms his appointment as Managing Director of <strong>BrainJuicer</strong> UK. The<br />

agreement can be terminated upon three months’ notice in writing by either party and includes<br />

restrictive covenants which apply during his employment and for a period of 12 months after its<br />

70

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!